Search Results - "Danforth AL"

Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trial.

Authors: Richardson, Candice Chan, Cindy Macgregor, Emily et al.

Source: Pilot & Feasibility Studies. 10/28/2025, Vol. 11 Issue 1, p1-11. 11p.

Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.

Authors: Borgogna, Nicholas C. Owen, Tyler Petrovitch, Dan et al.

Source: Psychopharmacology. Oct2025, Vol. 242 Issue 10, p2139-2157.

Radiation therapy patients' interest in psychedelic-assisted therapy: results of a survey.

Authors: Park, Jino Banks, Rufus Munjal, Akul et al.

Source: Radiation Oncology. 7/21/2025, Vol. 20 Issue 1, p1-10. 10p.

Investigating the impact of psychedelic drugs on social cognition defects: A scoping review protocol.

Authors: Smith, Sarah Ann Smith, Shaina Dennett, Liz et al.

Source: PLoS ONE. 7/29/2024, Vol. 19 Issue 7, p1-8. 8p.

Psilocybin therapy for treatment resistant depression: prediction of clinical outcome by natural language processing.

Authors: Dougherty, Robert F. Clarke, Patrick Atli, Merve et al.

Source: Psychopharmacology. Jul2025, Vol. 242 Issue 7, p1553-1561.

A Systematic Review of Interventions for Demoralization in Patients with Chronic Diseases.

Authors: Dong, Li Li, Li Wu, Yunlian et al.

Source: International Journal of Behavioral Medicine. Feb2025, Vol. 32 Issue 1, p1-10.

Bias and balance in psychedelic academia: a tricky business.

Authors: Bawks, Jordan Gomes, Fabiano A.

Source: Trends in Psychiatry & Psychotherapy. 2025, Vol. 47 Issue 1, p1-3. 3p.

Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties.

Authors: Atiq, Mazen A. Baker, Matthew R. Voort, Jennifer L. Vande et al.

Source: Psychopharmacology. Jul2025, Vol. 242 Issue 7, p1481-1506.

A protocol for a scoping review of variations among psychedelic interventions for psychological suffering associated with the end-of-life.

Authors: Kratina, Sarah Strike, Carol Schwartz, Robert et al.

Source: PLoS ONE. 5/6/2025, Vol. 20 Issue 5, p1-10. 10p.

Navigating groundlessness: An interview study on dealing with ontological shock and existential distress following psychedelic experiences.

Authors: Argyri, Eirini K. Evans, Jules Luke, David et al.

Source: PLoS ONE. 5/5/2025, Vol. 20 Issue 5, p1-28. 28p.

Moderating factors in psilocybin-assisted treatment affecting mood and personality: A naturalistic, open-label investigation.

Authors: Irrmischer, Mona Puxty, Drew Yıldırım, Barış Onur et al.

Source: Psychopharmacology. Apr2025, Vol. 242 Issue 4, p725-740.

Perceived changes in mental health and social engagement attributed to a single psychedelic experience in autistic adults: results from an online survey.

Authors: Stroud, Jack Rice, Charlotte Orsini, Aaron et al.

Source: Psychopharmacology. Feb2025, Vol. 242 Issue 2, p373-387.

Comparing Substance Use Consequences between Serotonergic Psychedelics, MDMA, and other Drugs of Abuse Among United States Adults with History of Psychiatric Illness.

Authors: Black, Joshua C. Schow, Nicole Burkett, Hannah L. et al.

Source: International Journal of Mental Health & Addiction. Apr2025, Vol. 23 Issue 2, p1179-1192. 14p.

Psychedelic therapy and cultural humility.

Authors: Gearin A Docherty J Sun X et al.

Source: Translational psychiatry [Transl Psychiatry] 2026 Feb 27; Vol. 16 (1). Date of Electronic Publication: 2026 Feb 27.

Publication Type: Journal Article; Review

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101562664 Publication Model: Electronic Cited Medium: Internet ISSN: 2158-3188 (Electronic) Linking ISSN: 21583188 NLM ISO Abbreviation: Transl Psychiatry Subsets: MEDLINE

Psychedelics for Patients Experiencing Existential Distress, Anxiety or Depression in Palliative Care.

Authors: Tanuseputro P Docherty J Sun X et al.

Source: CNS drugs [CNS Drugs] 2026 Jul 16. Date of Electronic Publication: 2026 Jul 16.

Publication Type: Editorial

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9431220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1934 (Electronic) Linking ISSN: 11727047 NLM ISO Abbreviation: CNS Drugs Subsets: MEDLINE

Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care.

Authors: Geller JA Pacilio R Downey AE et al.

Source: Current psychiatry reports [Curr Psychiatry Rep] 2026 May 14; Vol. 28 (1). Date of Electronic Publication: 2026 May 14.

Publication Type: Journal Article; Review

Journal Info: Publisher: Current Science Country of Publication: United States NLM ID: 100888960 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-1645 (Electronic) Linking ISSN: 15233812 NLM ISO Abbreviation: Curr Psychiatry Rep Subsets: MEDLINE

How three different theories of depression converge at inflammation.

Authors: Baumberger, B. Batey, L. Hashemi, P.

Source: Discover Mental Health. 12/24/2025, Vol. 5 Issue 1, p1-13. 13p.

Mapping the phenomenology of intranasal 5-MeO-DMT in psychedelic-naïve healthy adults.

Authors: Ermakova, Anna O. Dunbar, Fiona Seynaeve, Mathieu et al.

Source: Scientific Reports. 11/6/2025, Vol. 15 Issue 1, p1-17. 17p.

Reporting of side-effects in clinical trials of psilocybin-assisted psychotherapy for psychiatric conditions: systematic review.

Authors: Marinis, Jonathon Clarke, Sarah T. Guerin, Alexandre A. et al.

Source: BJPsych Open. Nov2025, Vol. 11 Issue 6, p1-9. 9p.

Impact of psilocybin on cognitive function: A systematic review.

Authors: Meshkat, Shakila Tello‐Gerez, Triana Juliana Gholaminezhad, Fatemeh et al.

Source: Psychiatry & Clinical Neurosciences. Dec2024, Vol. 78 Issue 12, p744-764. 21p.

Subjects: Cognitive processing speed, Cognitive flexibility, Nootropic agents, Cognition, Cognitive ability